Boehringer Ingelheim and Click Therapeutics expand collaboration to develop digital therapeutics for schizophrenia

Healthium launches Theruptor Novo for diabetic foot ulcers

Theruptor Novo is a best in class patented product which provides an optimum healing environment and addresses the concerns of chronic wound dressing

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences

Weizmann’s study sheds new light on a promising antidepressant

A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025

Urologists explore the role of robotics, equity, exercise and medicine on bladder cancer

Researchers presented these bladder cancer study findings at the 117th Annual Scientific Meeting of the American Urological Association (AUA)

Tirzepatide has potential to drive weight loss market dramatically, observes GlobalData

Tirzepatide is primarily indicated for the treatment of T2D and is expected to receive its decision from the FDA in Q2 2022

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo

Health Canada gives breakthrough approval for Dolphin Vagal Stim device to treat Covid-19

The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation

Lo.Li Pharma International seeks partners for Deplesin therapy

Deplesin is an add-on therapy to gold standard agents like lithium, valproic acid, and carbamazepine, supporting patients in ways that prescription medications often cannot